Traceability between SDTM and ADaM converted analysis datasets

Slides:



Advertisements
Similar presentations
Dimitri Kutsenko (Entimo AG)
Advertisements

CDISC based eSubmission Key Points of the CDISC SDTM/ADaM Pilot
Principal Statistical Programmer Accovion GmbH, Marburg, Germany
ADaM Implementation Guide: It’s Almost Here. Are You Ready?
FDA/Industry Statistics Workshop - 29 September 2006
Experience and process for collaborating with an outsource company to create the define file. Ganesh Sankaran TAKE Solutions.
Protocol Author Process People Technology
CDISC ADaM 2.1 Implementation: A Challenging Next Step in the Process Presented by Tineke Callant
The Importance of CDASH
Quick tour of CDISC’s ADaM standard
“Compliance” for Analysis Data Chris Decker, Vice-President, Life Sciences Practice, d-Wise Technologies Randall Austin, Manager, Data Standards, GlaxoSmithKline.
CDISC (CDASH/SDTM) integration into OC/RDC
Study Data Standardization Plan Kick0ff Meeting 23 July 2014.
Monika Kawohl Statistical Programming Accovion GmbH Tutorial: define.xml.
Accenture Accelerated R&D Standards Metadata Management – version control and its governance Kevin Lee CDISC NJ Meeting at 01/28/2015 We help our Clients.
Beyond regulatory submission - Standards Metadata Management Kevin Lee CDISC NJ Meeting at 06/17/2015 We help our Clients deliver better outcomes, so.
23 August 2015Michael Knoessl1 PhUSE 2008 Manchester / Michael Knoessl Implementing CDISC at Boehringer Ingelheim.
CBER CDISC Test Submission Dieter Boß CSL Behring, Marburg 20-Mar-2012.
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
PhUSE SDE, 28-May A SAS based Solution for define.xml Monika Kawohl Statistical Programming Accovion.
Contents Integrating clinical trial data Working with CROs
Vertex and CDISC / MBC / 12March Vertex and CDISC Accomplishments and Strategy 12 March 2008 Lynn Anderson Associate Director Statistical Programming/Biometrics.
Antje Rossmanith, Roche 14th German CDISC User Group, 25-Sep-2012
Overview and feed-back from CDISC European Interchange 2008 (From April 21 st to 25 th, COPENHAGEN) Groupe des Utilisateurs Francophones de CDISC Bagneux.
Confidential - Property of Navitas Accelerate define.xml using defineReady - Saravanan June 17, 2015.
MODULE B: Case Report Forms Jane Fendl & Denise Thwing April 7, Version: Final 07-Apr-2010.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
© Copyright 2008 ADaM Validation and Integrity Checks Wednesday 12 th October 2011 Louise Cross ICON Clinical Research, Marlow, UK.
SDTM Validation Delaware Valley CDISC user network Ketan Durve Johnson and Johnson Pharmaceutical Reasearch and Development May 11 th 2009.
February 17, 1999Open Forum on Metadata Registries 1 Census Corporate Statistical Metadata Registry By Martin V. Appel Daniel W. Gillman Samuel N. Highsmith,
Implementation of CDISC Standards at Nycomed PhUSE, Basel (19-21 October 2009) Nycomed GmbH, Dr. B Traub CDISC Implementation at Nycomed.
Research Project on Metadata Extraction, Exploration and Pooling: Challenges and Achievements Ronald Steinhau (Entimo AG - Berlin/Germany)
Research based, people driven CDISC ADaM Datasets - from SDTM to submission CDISC Experience Exchange and ADaM Workshop 15 Dec 2008 Zoë Williams, LEO Pharma.
WG4: Standards Implementation Issues with CDISC Data Models Data Guide Subteam Summary of Review of Proposed Templates and Next Steps July 23, 2012.
Optimizing Data Standards Working Group Meeting Summary
WG4: Data Guide/Data Description Work Group Meeting August 29, 2012.
Practical Image Management for Pharma Experiences and Directions. Use of Open Source Stefan Baumann, Head of Imaging Infrastructure, Novartis.
CDISC©2009 February CDISC INTRAchange Carey Smoak Device Team Leader Li Zheng Submission Data Standards Team Member Thurday, April 2, 2009.
CDISC User Group in Deutschland/Japan Hajime Shimizu (nickname: Akiba) CDISC Japan User Group introduction to team activity.
German Speaking CDISC UG, 22-Sep CDER Common Data Standards Issues Document Motivation CDISC submissions received varied more than expected Contents.
April ADaM define.xml - Metadata Design Analysis Results Metadata List of key analyses (as defined in change order) Analysis Results Metadata per.
© CDISC 2015 Paul Houston CDISC Europe Foundation Head of European Operations 1 CTR 2 Protocol Representation Implementation Model Clinical Trial Registration.
How Good is Your SDTM Data? Perspectives from JumpStart Mary Doi, M.D., M.S. Office of Computational Science Office of Translational Sciences Center for.
CDISC SDS Oncology Domains: An Orientation to Aid Review & Feedback Barrie Nelson CDISC SDS Oncology Sub Team Lead
ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC Joerg Guettner, Lead Statistical Analyst, Bayer Pharma, Wuppertal,
Dave Iberson-Hurst CDISC VP Technical Strategy
CTR: Clinical Trial Registries
Monika Kawohl Statistical Programming Accovion GmbH
Experience and process for collaborating with an outsource company to create the define file. Ganesh Sankaran TAKE Solutions.
Accelerate define.xml using defineReady - Saravanan June 17, 2015.
Definition SpecIfIcatIons
STDMIG-PGx Implementation in Clinical Trials Using Legacy PGx DB
Beyond regulatory submission - Standards Metadata Management Kevin Lee CDISC NJ Meeting at 06/17/2015 We help our Clients deliver better outcomes, so.
Accenture Accelerated R&D Standards Metadata Management – version control and its governance Kevin Lee CDISC NJ Meeting at 01/28/2015 We help our Clients.
Why use CDISC for trials not submitted to regulators?
MAKE SDTM EASIER START WITH CDASH !
CPT and Disclosure: Connecting Critical Processes
Freundschaft Konferenz
Patterns emerging from chaos
Definition SpecIfIcatIons
A SAS macro to check SDTM domains against controlled terminology
Fabienne NOEL CDISC – 2013, December 18th
CPT and Disclosure: Connecting Critical Processes
WG4: Data Guide/Data Description Work Group Meeting
SDTM and ADaM Implementation FAQ
Presenters Emily Woolley
An FDA Statistician’s Perspective on Standardized Data Sets
An exploration of quality gaps in SDTM implementation activities and ideas on how to address these gaps through appropriate resourcing Dianne Weatherall:
Optimzing the Use of Data Standards Calling for Volunteers
WHERE TO FIND IT – Accessing the Inventory
Presentation transcript:

Traceability between SDTM and ADaM converted analysis datasets

Topics Introduction ADaM Conversion Quality Control 1 Introduction 2 ADaM Conversion 3 Quality Control 4 Challenges & Conclusion

SDTM/ADaM adoption by FDA SDTM is expected to be « required for FDA submission » within 2 years CDER is accepting SDTM submissions CBER is accepting SDTM submissions since May 2010 CDRH interest is rising, CDISC SDTM team has formed a medical devices subteam FDA CDER: Requesting sponsors to submit in SDTM format Encouraging sponsors to submit in ADaM format Continuous FDA pilot projects, both CDER and CBER

Implementation approaches: strategy 1

Implementation approaches: strategy 2

Traceability SDTM and ADaM Understanding relationship between the analysis results, the analysis datasets and the SDTM domains Establishing the path between an element and its immediate predecessor Two levels: Metadata traceability Relationship between an analysis result and analysis dataset(s) Relationship of the analysis variable to its source dataset(s) and variable(s) Data point traceability Predecessor record(s)

Traceability SDTM and ADaM Analysis Results SDTM aCRF Analysis Dataset SDTM define.xml ADaM define.xml

Topics Introduction ADaM Conversion Quality Control 1 Introduction 2 ADaM Conversion 3 Quality Control 4 Challenges & Conclusion

ADaM Conversion: strategy 2

Number of studies and ADs Submission included 11 trials For each trial: ADSL (Subject Level Analysis Dataset) AD with baseline conditions AD with treatment administration AD with efficacy endpoints For some trials: 2 Pharmacokinetic datasets

Team Profile and Roles CRO Manager Project Manager CDISC expert support Project Manager Project Manager back-up Assigned for the duration of the project Single point of contact Mappers (4) ADaM experts Define mapping Investigate traceability Programmers (2.5) Create the conversions programs Perform peer review Data Steward (0.5) Maintains the consistency across the project Quality Checker (4) Perform ADaM datasets review Perform define.xml review

Conversion Types Creation of SDTM variables Variables like USUBJID which were created during the SDTM convertion Minor conversion Contents unchanged, metadata changes Change variable name and label of the age group variable Format values Content and metadata changes The content of the SEX variable had to be changed in order to reflect the SDTM values Transpose Observations become variables Populations in the ADSL dataset

Variables originating from SDTM Traceability Variables originating from SDTM SDTM variables are retained in ADaM ADs for traceability SDTM variables are unchanged same name, same type, same label (metadata) and same content (data) Derived variables Original computational algorithm for derived AD variable(s) based on original clinical database New computational algorithm needs to be based on SDTM database New computational algorithm is included into ADaM define.xml

Topics Introduction ADaM Conversion Quality Control 1 Introduction 2 ADaM Conversion 3 Quality Control 4 Challenges & Conclusion

QC is partially automated Quality Control QC is partially automated Electronic QC (CDISC Compliance Checks – SDTM&ADaM) Manual QC QC on Consistency (Data Steward) QC on: Mapping ADaM Datasets Define.xml Statistical Results QC is supported by documentation

QC Tier 1: CDISC Compliance Checks We have created an expanded & enhanced list of checks 154 WebSDM ™ checks Total check package: CDISC compliance checks list is growing continuously SDTMIG V3.1.1 SDTMIG V3.1.2 ADaMIG V1.0 Data checks 141 219 45 Metadata checks 68 117 51 Mapping checks 56 57 12 Project consistency checks 20

QC Tier 1: Application Flowchart

QC Tier 2: Manual QC 100% manual QC on a random sample Supported by checklists Supported by a QC content tool on source and target

QC Tier 3: Data Steward Maintains consistency of metadata across project Uses the metadata repository Electronic consistency checks

QC Tier 4: Statistical Results TRANSFORMATION TRANSFORMATION ADaM QC COMPARISON

QC Tier 4: Team Profile and Roles Project-/Trial Programmer (3) Coordination Single point of contact Project Statistician (1) Specifications of results subject to QC QC Programmers (3) Re-production of statistical results

Compilation of selected result-tables QC Tier 4 : Tasks Compilation of selected result-tables ~ 55 table types ~ 220 tables mainly descriptive statistics few inferential statistics (ANCOVA) Set-up of work environment e.g. directories, access rights Learning the project, trials QC Programming Recreate results from CTR / ISE Based on Pooled BI Analysis Datasets (initially) Based on ADaM (once available) Documenting QC progress Comparison of results

Report Source Data Issues Communication Topics Report Source Data Issues Empty variables Exclusion of screen failures Unclear computational algorithms Traceability issues with SDTM Sponsor Feedback Clarifications computational algorithms QC comments

Addressing and solving issues and deciding further proceedings in Communication Addressing and solving issues and deciding further proceedings in weekly T*C with representatives from each of the 3 subteams daily brief QC Programmers meeting Communication was: Timely and immediate Focused For some last minute changes to ADaM, communication was not effective e.g. renaming of variables data changes due to B&D Life Sciences QC, e.g. indicator variables

Topics Introduction ADaM Conversion Quality Control 1 Introduction 2 ADaM Conversion 3 Quality Control 4 Challenges & Conclusion

Learning the project / trials Challenges Learning the project / trials Understanding original analysis datasets and computational algorithms Finding all QC relevant result tables Initially some wrong tables selected Transformation from trial to pooled ADs not clearly documented This type of project is always on critical path for a submission Short timelines Large team

Conclusion We now understand better how FDA feels SDTM is the basis for analysis and therefore needs to be complete Results in the clinical study report must be reproducible by FDA reviewers from the newly created ADaM analysis datasets Traceability most difficult part in ADaM conversion Familiarization with usage of ADaM for programming was minimal Due to similarity of ADaM with BI-ADs structure Relatively straightforward to program from ADaM In an ideal world, analysis datasets are created from SDTM datasets, thereby ensuring 100% traceability